Skip to main content

Page of 4
and
  1. No Access

    Article

    Endothelial injury in sepsis

    Marcel Levi, Tom van der Poll in Intensive Care Medicine (2013)

  2. Article

    Another step in improving the diagnosis of disseminated intravascular coagulation in sepsis

    The diagnosis of disseminated intravascular coagulation (DIC) based on composite scoring systems using routinely available coagulation tests has been greatly facilitated. Such scoring instruments not only adeq...

    Marcel Levi in Critical Care (2013)

  3. No Access

    Article

    Disseminated intravascular coagulation: a review for the internist

    Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic intravascular activation of coagulation, leading to widespread deposition of fibrin in the circulation. Recent knowledge on ...

    Marcel Levi, Tom van der Poll in Internal and Emergency Medicine (2013)

  4. No Access

    Chapter

    Wat kun je als promovendus verwachten en wat wordt er van je verwacht?

    Het leven van een promovendus is niet altijd eenvoudig. Op onverklaarbare wijze willen de gekweekte cellen niet meer delen, gaan alle muizen tijdens het experiment voortijdig dood en zijn er in geen velden of ...

    Marcel Levi in Promoveren doe je zo! (2013)

  5. Article

    Open Access

    Protease-activated receptor-1 impairs host defense in murine pneumococcal pneumonia: a controlled laboratory study

    Streptococcus pneumoniae is the most common causative pathogen in community-acquired pneumonia. Protease-activated receptor-1 (PAR-1) is expressed by multiple cell types present in the lungs and can be activated ...

    Marcel Schouten, Cornelis van't Veer, Joris JTH Roelofs, Marcel Levi in Critical Care (2012)

  6. Article

    Open Access

    Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome – a retrospective propensity matched cohort study

    Acute lung injury (ALI) is characterized by a pro-coagulant state. Heparin is an anticoagulant with anti-inflammatory properties. Unfractionated heparin has been found to be protective in experimental models o...

    Jorrit J Hofstra, Alexander P J Vlaar, David J Prins, Gavin Koh in BMC Pulmonary Medicine (2012)

  7. Article

    Open Access

    Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigations

    Data from interventional trials of systemic anticoagulation for sepsis inconsistently suggest beneficial effects in case of acute lung injury (ALI). Severe systemic bleeding due to anticoagulation may have off...

    Pieter R Tuinman, Barry Dixon, Marcel Levi, Nicole P Juffermans in Critical Care (2012)

  8. Article

    Open Access

    Systemic versus localized coagulation activation contributing to organ failure in critically ill patients

    In the pathogenesis of sepsis, inflammation and coagulation play a pivotal role. Increasing evidence points to an extensive cross-talk between these two systems, whereby inflammation not only leads to activati...

    Marcel Levi, Tom van der Poll, Marcus Schultz in Seminars in Immunopathology (2012)

  9. Article

    Open Access

    Acute Stress Elicited by Bungee Jum** Suppresses Human Innate Immunity

    Although a relation between diminished human immunity and stress is well recognized both within the general public and the scientific literature, the molecular mechanisms by which stress alters immunity remain...

    David J. van Westerloo, Goda Choi, Ester C. Löwenberg, Jasper Truijen in Molecular Medicine (2011)

  10. Article

    Open Access

    Blood transfusion during cardiac surgery is associated with inflammation and coagulation in the lung: a case control study

    Blood transfusion is associated with increased morbidity and mortality in cardiac surgery patients, but cause-and-effect relations remain unknown. We hypothesized that blood transfusion is associated with chan...

    Pieter R Tuinman, Alexander P Vlaar, Alexander D Cornet, Jorrit J Hofstra in Critical Care (2011)

  11. Article

    Treatment with recombinant human activated protein C: one size does not fit all

    Protein C plays an important role in the coagulopathy associated with sepsis and probably also in the pathogenesis of sepsis-induced organ dysfunction. Plasma levels of protein C strongly correlate with clinic...

    Marcel Levi in Critical Care (2011)

  12. Article

    Open Access

    Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study

    Streptococcus (S.) pneumoniae is the most common cause of community-acquired pneumonia. The factor V Leiden (FVL) mutation results in resistance of activated FV to inactivation by activated protein C and thereby ...

    Marcel Schouten, Cornelis van't Veer, Joris JTH Roelofs, Marcel Levi in Critical Care (2010)

  13. Article

    Open Access

    2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

    We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) and updated this as Hereditary angio...

    Tom Bowen, Marco Cicardi, Henriette Farkas in Allergy, Asthma & Clinical Immunology (2010)

  14. Article

    Adequate thromboprophylaxis in critically ill patients

    Venous thromboembolism is a relatively frequently occurring complication in critically ill patients admitted to the ICU despite prophylactic treatment with subcutaneous low molecular weight heparin. Several st...

    Marcel Levi in Critical Care (2010)

  15. Article

    Open Access

    Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats

    Disturbed alveolar fibrin turnover is a cardinal feature of severe pneumonia. Clinical studies suggest that natural inhibitors of coagulation exert lung-protective effects via anticoagulant and possibly also a...

    Jorrit J Hofstra, Alexander D Cornet, Bart F de Rooy, Alexander P Vlaar in Critical Care (2009)

  16. Article

    Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis

    Mitchell Levy, Marcel Levi, Mark D. Williams, Massimo Antonelli in Intensive Care Medicine (2009)

  17. Article

    Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis

    The safety of using heparin concomitantly with drotrecogin alfa (activated) {DrotAA} was explored in the XPRESS study. No heparin effect on mortality was observed. Safety results from that study are explored i...

    Mitchell Levy, Marcel Levi, Mark D. Williams, Massimo Antonelli in Intensive Care Medicine (2009)

  18. No Access

    Article

    Emergency reversal of antithrombotic treatment

    The most important adverse effect of antithrombotic treatment is the occurrence of bleeding. In case of serious or even life-threatening bleeding in a patient who uses anticoagulant agents or when a patient on...

    Marcel Levi in Internal and Emergency Medicine (2009)

  19. Article

    Open Access

    Improvement in the regulation of the vitamin K antagonist acenocoumarol after a standard initial dose regimen: prospective validation of a prescription model

    Background In a retrospective study we have developed a model which determines the dose of acenocoumarol based on the age of the patient and on the first INR obtained after a standard ini...

    Johanna H. H. Van Geest-Daalderop in Journal of Thrombosis and Thrombolysis (2009)

  20. Article

    The inflammation–coagulation axis as an important intermediate pathway in acute lung injury

    Markers of inflammation, coagulation, and fibrinolysis predict an adverse outcome in patients with sepsis. These markers also seem predictive of an adverse outcome in patients with localized infection and infl...

    Marcel Levi, Marcus Schultz in Critical Care (2008)

Page of 4